|
|
|||||||||||
Department of Psychiatry and Psychotherapy, University of Cologne, Germany
Department of Psychiatry and Psychotherapy, University of Bonn, Germany
Department of Psychiatry and Psychotherapy, University of Cologne, Germany
Department of Psychiatry and Psychotherapy, Heinrich-Heine-University, Düsseldorf, Germany
Central Institute of Mental Health, Mannheim, Germany
Heinrich-Heine-University, Düsseldorf, Germany
Department of Psychiatry and Psychotherapy, University of Munich, Germany
Department of Psychiatry and Psychotherapy, University of Bonn, Germany
Department of Psychiatry and Psychotherapy, University of Cologne, Germany
Correspondence: Stephan Ruhrmann, MD, Department of Psychiatry and Psychotherapy, University Hospital of the University of Cologne, Kerpener Strasse 62, 50924 Cologne, Germany. Email: stephan.ruhrmann{at}uk-koeln.de
Declaration of interest None. Funding detailed in Acknowledgements.
Background People in a putatively late prodromal state not only have an enhanced risk for psychosis but already suffer from mental and functional disturbances.
Aims To evaluate the acute effects of a combined supportive and antipsychotic treatment on prodromal symptoms.
Method Putatively prodromal individuals were randomly assigned to a needs-focused intervention without (n=59) or with amisulpride (n=65). Outcome measures at 12-weeks effects were prodromal symptoms, global functioning and extrapyramidal side-effects.
Results Amisulpride plus the needs-focused intervention produced superior effects on attenuated and full-blown psychotic symptoms, basic, depressive and negative symptoms, and global functioning. Main side-effects were prolactin associated.
Conclusions Coadministration of amisulpride yielded a marked symptomatic benefit. Effects require confirmation by a placebo-controlled study.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Psychiatric Bulletin | Advances in Psychiatric Treatment | All RCPsych Journals |